Goodyeroside A

CAS No. 211107-44-7

Goodyeroside A( ——— )

Catalog No. M38399 CAS No. 211107-44-7

Goodyeroside A is a glycoside compound derived from the plant Goodyera that exhibits significant hepatoprotective activity. It can inhibit liver damage induced by carbon tetrachloride in primary cultured rat hepatocytes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Goodyeroside A
  • Note
    Research use only, not for human use.
  • Brief Description
    Goodyeroside A is a glycoside compound derived from the plant Goodyera that exhibits significant hepatoprotective activity. It can inhibit liver damage induced by carbon tetrachloride in primary cultured rat hepatocytes.
  • Description
    Goodyeroside A is a glycoside compound derived from the plant Goodyera that exhibits significant hepatoprotective activity.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    211107-44-7
  • Formula Weight
    264.23
  • Molecular Formula
    C10H16O8
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Du XM, et al. Hepatoprotective aliphatic glycosides from three Goodyera species. Biol Pharm Bull. 2000 Jun;23(6):731-4. ?
molnova catalog
related products
  • 2,4-Dihydroxy-4,6-di...

    2,4-Dihydroxy-4,6-dimethoxydihydrochalcone is a natural product for research related to life sciences.

  • ReACp53

    ReACp53 is a cell-penetrating peptide, designed to inhibit p53 amyloid formation, resues p53 function in cancer cell lines and in organoids derived from high-grade serous ovarian carcinomas (HGSOC).

  • PF-04457845

    PF-04457845 is a greatly and effctive FAAH inhibitor, and for hFAAH(IC50=7.2±0.63 nM) and rFAAH(IC50=7.4±0.62 nM).